Company / Net Income
Nuo Therapeutics, Inc. Net Income History
FY2011-FY2017 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Net Income
-$15.0M
FY2017
5-year range
-$52.8M / -$5.7M
FY2013-FY2017
Trend
-163.0%
vs FY2016
Sector context
Sector data unavailable
Latest sector comparison
What the data says
Net Income has fluctuated over the past 7 years, ranging from -$53M in FY2015 to -$4M in FY2011.
Based on SEC 10-K filings.
-$15M in FY2017.
Improved from -$53M to -$15M over the past 2 years.
Net Income over time
Growth rates
- 3-Year CAGR
- -
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Key checks
Key Insights
- In FY2017, net income decreased 163.0% year-over-year.
- Peak net income was recorded in FY2011.
- Lowest net income in the period was in FY2015.
Company context
Key Data Points
- Altman Z-Score -45.34 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Net IncomeValue | YoY GrowthYoY |
|---|---|---|
| FY2017 | -$15.0M | -163.0% |
| FY2016 | -$5.7M | +89.2% |
| FY2015 | -$52.8M | -179.7% |
| FY2014 | -$18.9M | +6.7% |
| FY2013 | -$20.2M | -2.3% |
| FY2012 | -$19.8M | -464.0% |
| FY2011 | -$3.5M | - |
As of FY2017 · SEC 10-K · Updated Jun 29, 2026